Skip to content

The Safety and Effectiveness of CVA-FLOW Software Device for Acute Ischemic Stroke

A Single-center, Clinical Trial to Evaluate the Safety and Effectiveness of CVA-FLOW Software Device for Acute Ischemic Stroke

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05745051
Enrollment
100
Registered
2023-02-27
Start date
2022-11-08
Completion date
2023-11-30
Last updated
2023-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Stroke, Acute, Stroke, Cardiovascular, Stroke Hemorrhagic, Stroke, Ischemic

Brief summary

The purpose of this study is to demonstrate the effectiveness and safety of CVA-FLOW, a digital health AI based Telestroke system developed by CVAID Ltd. Company aims to assist certified medical staff to triage acute ischemic stroke patients using dedicated algorithms in order to support application for market approval for CVA-FLOW device.

Interventions

DIAGNOSTIC_TESTCVAid Flow

CVA-FLOW is a Telestroke mobile software solution that enables the neurologist to remotely assess, on his smartphone, patients suspected with stroke. Real-time, objective, patient-specific data such as images, videos and vocal records of the patient, are acquired by a first responder (CVA-COLLECTOR) at the patient's location. This allows the neurologist to complete the NIH Stroke Scale and independently reach a diagnostic conclusion and treatment plan (CVA-MED).

Sponsors

Cvaid Medical
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Suspected hyper-acute stroke patient at the ED, prior to treatment (tPA or EVT) * Age≥18

Exclusion criteria

* Intubated patients upon arrival * Time from stroke symptoms onset \> 24h * Patients post treatment (tPA of EVT) * Patient in acute psychosis state * Patients who do not speak Hebrew as their mother tongue

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and specificity of stroke severity classification by CVA-CORE algorithmAt admissionStroke severity classification will be calculated by the CVA-CORE system algorithm and compared to the imaging results (interpretation).

Secondary

MeasureTime frameDescription
Device operational performanceAt admissionThe investigator shall assess the use of the device during the operation, and conclude a summary evaluation after the end of the usage. Evaluation items are shown below:Item / evaluation * Usage experience: Simple to operate/difficult to operate * Errors: No errors occurs during the usage/ Errors occurs during the usage * Known safety issues during use of CVA-MED and CVA-COLLECTOR

Countries

Israel

Contacts

Primary ContactOren Dror
oren@cvaidmedical.com+972 54-922-5676

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026